LamassuBiotech
  • Company
    • Mission & History
    • Leadership & Key Collaborators
    • Partners
  • The Lamassu Method
  • Pipeline
    • SA53
    • RABI-767
  • Lamassu Pets
  • Investor Resources
    • Investor Resources
    • Events & Presentations
  • News
    • News Releases
    • Media Coverage
  • Contact Us

Author: Bob Driscoll

08/06/2024

Newsmax Magazine: New Approach to Cancer Treatment

A new type of cancer drug could transform the treatment for many deadly cancers, especially those that have advanced or metastasized and do not respond to other therapies. Rather than...
READ THE ARTICLE
07/12/2024

Cleveland Plains Dealer: Cancer Moonshot Requires More than Money 

Few challenges loom larger for humanity than the fight against cancer. Cancer is an adversary that demands an approach that harnesses the latest technology and the best instincts of the...
READ THE ARTICLE
06/14/2024

Pharma Exec: Lamassu Pharma Bridges Scientific Knowledge and Patient Care

In the realm of drug development, the industry puts a great deal of emphasis on centering the patient experience. As a result, it is imperative that drug developers consider how...
READ THE ARTICLE

Posts navigation

Older posts
Newer posts

Recent Posts

  • CLINICAL TRIAL OF LAMASSU BIOTECH’S SA-53 MDM2 INHIBTOR CONTINUES TO PRODUCE SIGNIFICANT PROGRESS AND FAVORABLE SAFETY PROFILE
  • Crain’s Cleveland Business: Former FDA leader appointed to Lamassu Biotech board of directors
  • FORMER FDA COMMISSIONER DR. STEPHEN HAHN JOINS LAMASSU BIOTECH BOARD OF DIRECTORS
  • Ohio State Launches Clinical Trial for Promising New Treatment for Acute Pancreatitis in Dogs
  • RBV Quarterly: CEO Insights: Dr Gabi Hanna, Lamassu Biotech

Recent Comments

No comments to show.

Archives

  • May 2026
  • April 2026
  • March 2026
  • January 2026
  • November 2025
  • October 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • February 2025
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • April 2021
  • August 2020
  • March 2020

Categories

  • media
  • news
  • Uncategorized

Menu

  • Investor Resources
  • News Releases
  • Contact us

Questions?

1-919-246-3969

info@lamassubio.com

  • Privacy Statement
  • Terms Of Use
  • Accessibility
  • FCOI Policies